supaso.com

What It Is

Supaso International L.L.C. is a consulting firm that provides support on U.S. FDA regulations. Its website emphasizes that its consultants are former career officials at the U.S. FDA, and that it offers compliance support for medical devices, pharmaceuticals, food, BIMO, and related FDA programs. It is worth noting that, based on the crawled content, this is not a typical SaaS or enterprise software platform. Instead, it is a professional services provider centered on expert consulting, training, and inspection readiness.

Core Features and Service Scope

Its main services include general FDA regulatory advice, mock inspections using the same tools as the FDA, customized training on FDA regulatory programs, and support for corrective responses to regulatory documents such as FDA-483s, Warning Letters, and Untitled Letters. The service process also mentions comprehensive consulting to identify compliance gaps and regulatory risks, with reports that include project plans and simulated FDA-483 observations. The website does not provide information about software-style capabilities such as third-party integrations, team permissions, APIs, developer support, or cloud/self-hosted deployment.

Pricing and Trial

Pricing information is very limited. The page shows “Set Up Initial Meeting $0.00,” but also states that users need to get in touch to confirm scheduling and payment for online or phone meetings. Therefore, it can only be inferred that the company may offer a free initial meeting or booking entry point. Formal consulting fees, packages, hourly rates, and project-based pricing are not disclosed.

Pros and Cons

Its strengths are clear positioning and a strong focus on FDA inspections, CGMP, QMS, and remediation scenarios. The background of former FDA officials may be attractive to companies that need to understand how regulatory enforcement works in practice. It also covers pre-inspection preparation, training, and responses to regulatory correspondence. The drawbacks are that the website provides relatively little information, with no customer case studies, detailed consultant biographies, delivery timelines, success stories, or standard pricing. As a SaaS evaluation target, it offers almost no description of productized software functionality.

Best Fit and Access from China

It is best suited for medical device, pharmaceutical, and food companies that are planning to enter, or have already entered, the U.S. market and are facing FDA inspection or remediation pressure—especially teams that need expert human guidance rather than system-based tools. Access from China cannot be determined from the available text, and payment methods are not disclosed. Chinese companies that need localized communication, Chinese-language deliverables, or convenient cross-border payments may also want to compare local FDA registration, GMP/QMS, and medical device regulatory consulting firms.